Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Dr. Anil Philip is currently working as Associate Dean (Head), School of Pharmacy, University of Nizwa, Oman. Among other credentials, he served as a member of the Health and Social Sciences sectorial grant committee of The Research Council, Oman, and as Faculty Mentored Undergraduate Research Program general supervisor to promote undergraduate research at the University of Nizwa. His research objectives and achievements have been in controlling/modifying the release of small/large molecules targeted to GI space using phase-transited delivery systems. He has worked extensively in the field of controlled/ modified drug release systems. Currently, his research focuses on developing nano-drug delivery systems, which can be targeted to the various body organs. He has guided students in areas of targeted drug delivery, has more than 40 original research publications in international peer-reviewed journals, and two patents on drug delivery systems. Dr. Sankha Bhattacharya did his Post Doctorate from the Indian Institute of Technology (BHU), Varanasi, INDIA (August 2018-August 2019) in cancer nanomedicine and molecular pharmaceutics. He is currently serving as an Associate Professor in the Department of Pharmaceutics, School of Pharmacy & Technology Management Shirpur, SVKM'S NMIMS Deemed-to-be University, India with 9.3 years of Research and Teaching experiences. He has published more than 32 national and 18 international papers in high impact factor and peer-reviewed journals. He also published five book chapters on the global platform.

• 1. Colorectal Cancer: Understanding of disease2. Impact of the microbiome on colorectal cancer development3. Advanced Microfluidic Systems for the colorectal cancer diagnosis and its clinical application4. Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis5. Current drug therapy in Colorectal Cancer6. Recent advancements in Immunotherapy in colon cancer targeting7. Novel targeting formulations in Colorectal Cancer8. Polymeric nanoparticles in Colorectal Cancer9. Lipid nanoparticles in Colorectal Cancer10. Micro, nano emulsions in Colorectal Cancer11. A unique compilation of Whole-Systems approaches to curtail colon cancer through Herbal Medicine12. Bacteriotherapy in Colorectal cancer13. Biomarker and theranostic in colorectal cancer14. Advance precision medicine to combat colorectal cancer15. Recent updates of clinical trials for Colorectal Cancer16. Disease Models in Colorectal Cancer Research17. An Outlook into Liposomal Drug Delivery of Chemotherapeutic Agents to Combat Colorectal Cancer18. Novel targeting strategies on signaling pathway-Responsible for colorectal cancer19. Decipher the role of Cancer Stem Cells in Colorectal Cancer based on molecular pathology and its clinical significance

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Dr. Anil Philip is currently working as Associate Dean (Head), School of Pharmacy, University of Nizwa, Oman. Among other credentials, he served as a member of the Health and Social Sciences sectorial grant committee of The Research Council, Oman, and as Faculty Mentored Undergraduate Research Program general supervisor to promote undergraduate research at the University of Nizwa. His research objectives and achievements have been in controlling/modifying the release of small/large molecules targeted to GI space using phase-transited delivery systems. He has worked extensively in the field of controlled/ modified drug release systems. Currently, his research focuses on developing nano-drug delivery systems, which can be targeted to the various body organs. He has guided students in areas of targeted drug delivery, has more than 40 original research publications in international peer-reviewed journals, and two patents on drug delivery systems. Dr. Sankha Bhattacharya did his Post Doctorate from the Indian Institute of Technology (BHU), Varanasi, INDIA (August 2018-August 2019) in cancer nanomedicine and molecular pharmaceutics. He is currently serving as an Associate Professor in the Department of Pharmaceutics, School of Pharmacy & Technology Management Shirpur, SVKM'S NMIMS Deemed-to-be University, India with 9.3 years of Research and Teaching experiences. He has published more than 32 national and 18 international papers in high impact factor and peer-reviewed journals. He also published five book chapters on the global platform.

• 1. Colorectal Cancer: Understanding of disease2. Impact of the microbiome on colorectal cancer development3. Advanced Microfluidic Systems for the colorectal cancer diagnosis and its clinical application4. Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis5. Current drug therapy in Colorectal Cancer6. Recent advancements in Immunotherapy in colon cancer targeting7. Novel targeting formulations in Colorectal Cancer8. Polymeric nanoparticles in Colorectal Cancer9. Lipid nanoparticles in Colorectal Cancer10. Micro, nano emulsions in Colorectal Cancer11. A unique compilation of Whole-Systems approaches to curtail colon cancer through Herbal Medicine12. Bacteriotherapy in Colorectal cancer13. Biomarker and theranostic in colorectal cancer14. Advance precision medicine to combat colorectal cancer15. Recent updates of clinical trials for Colorectal Cancer16. Disease Models in Colorectal Cancer Research17. An Outlook into Liposomal Drug Delivery of Chemotherapeutic Agents to Combat Colorectal Cancer18. Novel targeting strategies on signaling pathway-Responsible for colorectal cancer19. Decipher the role of Cancer Stem Cells in Colorectal Cancer based on molecular pathology and its clinical significance

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Dr. Anil Philip is currently working as Associate Dean (Head), School of Pharmacy, University of Nizwa, Oman. Among other credentials, he served as a member of the Health and Social Sciences sectorial grant committee of The Research Council, Oman, and as Faculty Mentored Undergraduate Research Program general supervisor to promote undergraduate research at the University of Nizwa. His research objectives and achievements have been in controlling/modifying the release of small/large molecules targeted to GI space using phase-transited delivery systems. He has worked extensively in the field of controlled/ modified drug release systems. Currently, his research focuses on developing nano-drug delivery systems, which can be targeted to the various body organs. He has guided students in areas of targeted drug delivery, has more than 40 original research publications in international peer-reviewed journals, and two patents on drug delivery systems. Dr. Sankha Bhattacharya did his Post Doctorate from the Indian Institute of Technology (BHU), Varanasi, INDIA (August 2018-August 2019) in cancer nanomedicine and molecular pharmaceutics. He is currently serving as an Associate Professor in the Department of Pharmaceutics, School of Pharmacy & Technology Management Shirpur, SVKM'S NMIMS Deemed-to-be University, India with 9.3 years of Research and Teaching experiences. He has published more than 32 national and 18 international papers in high impact factor and peer-reviewed journals. He also published five book chapters on the global platform.

• 1. Colorectal Cancer: Understanding of disease2. Impact of the microbiome on colorectal cancer development3. Advanced Microfluidic Systems for the colorectal cancer diagnosis and its clinical application4. Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis5. Current drug therapy in Colorectal Cancer6. Recent advancements in Immunotherapy in colon cancer targeting7. Novel targeting formulations in Colorectal Cancer8. Polymeric nanoparticles in Colorectal Cancer9. Lipid nanoparticles in Colorectal Cancer10. Micro, nano emulsions in Colorectal Cancer11. A unique compilation of Whole-Systems approaches to curtail colon cancer through Herbal Medicine12. Bacteriotherapy in Colorectal cancer13. Biomarker and theranostic in colorectal cancer14. Advance precision medicine to combat colorectal cancer15. Recent updates of clinical trials for Colorectal Cancer16. Disease Models in Colorectal Cancer Research17. An Outlook into Liposomal Drug Delivery of Chemotherapeutic Agents to Combat Colorectal Cancer18. Novel targeting strategies on signaling pathway-Responsible for colorectal cancer19. Decipher the role of Cancer Stem Cells in Colorectal Cancer based on molecular pathology and its clinical significance